These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2081485)

  • 1. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
    Chawla RK; Bonkovsky HL; Galambos JT
    Drugs; 1990; 40 Suppl 3():98-110. PubMed ID: 2081485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosyl-L-methionine modulates Na+ + K+-ATPase activity in rat colonic basolateral membranes.
    Brown MD; Dudeja PK; Brasitus TA
    Biochem J; 1988 Apr; 251(1):215-22. PubMed ID: 2839160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach.
    Muriel P; Suarez OR; Gonzalez P; Zuñiga L
    J Hepatol; 1994 Jul; 21(1):95-102. PubMed ID: 7963428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
    Almasio P; Bortolini M; Pagliaro L; Coltorti M
    Drugs; 1990; 40 Suppl 3():111-23. PubMed ID: 2081476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Na+-H+ exchange by transmethylation reactions in rat colonic brush-border membranes.
    Dudeja PK; Foster ES; Brasitus TA
    Biochim Biophys Acta; 1986 Jul; 859(1):61-8. PubMed ID: 3013313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.
    Mato JM; Corrales F; Martin-Duce A; Ortiz P; Pajares MA; Cabrero C
    Drugs; 1990; 40 Suppl 3():58-64. PubMed ID: 2081481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis.
    Pisi E; Marchesini G
    Drugs; 1990; 40 Suppl 3():65-72. PubMed ID: 2081482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ademetionine: the state of the art and future prospects].
    Almasio P; Pagliaro L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():52S-55S. PubMed ID: 8117523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism.
    Friedel HA; Goa KL; Benfield P
    Drugs; 1989 Sep; 38(3):389-416. PubMed ID: 2680435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.
    Kaye GL; Blake JC; Burroughs AK
    Drugs; 1990; 40 Suppl 3():124-8. PubMed ID: 2081477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choline may be an essential nutrient in malnourished patients with cirrhosis.
    Chawla RK; Wolf DC; Kutner MH; Bonkovsky HL
    Gastroenterology; 1989 Dec; 97(6):1514-20. PubMed ID: 2511054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropharmacology of S-adenosyl-L-methionine.
    Baldessarini RJ
    Am J Med; 1987 Nov; 83(5A):95-103. PubMed ID: 3318448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 16. S-Adenosylmethionine protects against cyclosporin A-induced alterations in rat liver plasma membrane fluidity and functions.
    Galán AI; Muñoz ME; Jiménez R
    J Pharmacol Exp Ther; 1999 Aug; 290(2):774-81. PubMed ID: 10411591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosylmethionine metabolism and liver disease.
    Mato JM; Martínez-Chantar ML; Lu SC
    Ann Hepatol; 2013; 12(2):183-9. PubMed ID: 23396728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction of dietary methyl donors limits methionine availability and affects the partitioning of dietary methionine for creatine and phosphatidylcholine synthesis in the neonatal piglet.
    Robinson JL; McBreairty LE; Randell EW; Brunton JA; Bertolo RF
    J Nutr Biochem; 2016 Sep; 35():81-86. PubMed ID: 27469995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.
    Anstee QM; Day CP
    J Hepatol; 2012 Nov; 57(5):1097-109. PubMed ID: 22659519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine.
    Rafique S; Guardascione M; Osman E; Burroughs AK; Owen JS
    Clin Sci (Lond); 1992 Sep; 83(3):353-6. PubMed ID: 1327655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.